天然化合物作为miRNAs调节剂:在膀癌治疗中的新前沿
Ahmed I Abulsoud1,2, Shaza H Aly3, Sherif S Abdel Mageed4
1Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Nasr City, Cairo, 11231, Egypt.
Medical oncology (Northwood, London, England)
|January 30, 2025
概括
包括多和黄在内的天然化合物在调节膀癌 (BC) 治疗中的微RNA (miRNA) 方面表现有前途. 这些药物通过调节癌细胞生长和死亡,为传统化疗提供了潜在的更安全的替代品.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 膀癌 (BC) 是一个重大的全球健康挑战,复发率高,治疗选择有限.
- 微RNAs (miRNAs) 越来越多地被认为对膀癌的发展起作用,影响细胞增殖和入侵.
- 目前的BC治疗通常涉及化疗,这可能会产生显著的副作用.
研究的目的:
- 审查天然产品作为小RNA调节剂的潜力,用于膀癌管理.
- 探索植物化学物质影响癌细胞性质的机制.
- 讨论自然化合物的整合到现有的BC治疗策略中.
主要方法:
- 对研究自然化合物及其对膀癌中miRNAs的影响的文献综述.
- 对聚醇,黄类药物和其他植物化学物质的研究分析.
- 检查纳米颗粒在提供自然化合物的作用.
主要成果:
- 诸如多和黄类的天然产品具有固有的miRNA调节能力.
- 这些化合物可以通过调节细胞生长和亡来逆转膀癌细胞的瘤性质.
- 纳米粒子配方增强了这些天然剂的输送和有效性.
结论:
- 自然化合物代表了通过miRNA调制治疗膀癌的有希望的途径.
- 植物化学品提供了一个潜在的更安全和更有效的替代品或常规化疗的辅助.
- 对自然化合物及其纳米粒子传递系统的进一步研究可能会导致新的BC治疗方法.
更多相关视频
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.6K
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.2K
相关概念视频
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K